Unexpected cytotoxicity of a triisopropylsilylated syringaldehyde derived cinnamic acid amide
AbstractA small series of substituted cinnamic acid amides was prepared and screened for their cytotoxic activity. As a rather astonishing and unprecedented result, compound 5 holding a triisopropylsilyl (TIPS) protecting group at position 4 of the aromatic ring was highly cytotoxic (EC50 = 3.2 mM for HT29 human colon adenocarcinoma cells) while analogs with a methoxy or hydroxyl group at this position were of low cytotoxicity or not cytotoxic at all.
- A. Gunia-KrzyÅ¼ak, K. SÅ‚oczyÅ„ska, J. PopiÃ³Å‚, P. Koczurkiewicz, H. Marona, E. PÄ™kala, Cinnamic acid derivatives in cosmetics: current use and future prospects, Int. J. Cosmet. Sci. 2018, 40, 356-366.
- E. Pontiki, A. Peperidou, I. Fotopoulos, D. Hadjipavlou-Litina, Cinnamate hybrids: A unique family of compounds with multiple biological activities, Curr. Pharm. Biotechnol. 2018, 19, 1019-1048.
- K. Rajendran, A. Anwar, N.A. Khan, M.R. Shah, R. Siddiqui, Trans-Cinnamic Acid Conjugated Gold Nanoparticles as Potent Therapeutics against Brain-Eating Amoeba Naegleria fowleri, ACS Chem. Neurosci. 2019, 10, 2692-2696.
- S.A. Tishina, V.S. Stroylov, I.A. Zanyatkin, A.K. Melnikova, V.I. Muronetz, Y.Y. Stroylova, Cinnamic acid derivatives as the potential modulators of prion aggregation, Mendeleev Commun. 2017, 27, 493-494.
- S. Ullah, D. Kang, S. Lee, M. Ikram, C. Park, Y. Park, S. Yoon, P. Chun, H.R. Moon, Synthesis of cinnamic amide derivatives and their anti-melanogenic effect in Î±-MSH-stimulated B16F10 melanoma cells, Eur. J. Med. Chem. 2019, 161, 78-92.
- S. Ullah, C. Park, M. Ikram, D. Kang, S. Lee,
J. Yang, Y. Park, S. Yoon, P. Chun, H.R. Moon, Tyrosinase inhibition and anti-melanin generation effect of cinnamamide analogues, Bioorg. Chem. 2019, 87, 43-55.
- R. Wang, W. Yang, Y. Fan, W. Dehaen, Y. Li, H. Li, W. Wang, Q. Zheng, Q. Huai, Design and synthesis of the novel oleanolic acid-cinnamic acid ester derivatives and glycyrrhetinic acid-cinnamic acid ester derivatives with cytotoxic properties, Bioorg. Chem. 2019, 88, 102951. doi: 10.1016/j.bioorg.2019.102951.
- K. Yang, Y. Li, Q. Tang, L. Zheng, D. He, Synthesis, mitochondrial localization of fluorescent derivatives of cinnamamide as anticancer agents, Eur. J. Med. Chem. 2019, 170, 45-54.
- I. R.S. Baliza, S.L.R. Silva, L.D. Santos, J.H.A. Neto, R.B. Dias, C.B.S. Sales, C.A.G. Rocha, M.B.P. Soares, A.A. Batista, D.P. Bezerra, Ruthenium Complexes With Piplartine Cause Apoptosis Through MAPK Signaling by a p53-Dependent Pathway in Human Colon Carcinoma Cells and Inhibit Tumor Development in a Xenograft Model, Front. Oncol. 2019, 9, doi: 10.3389/fonc.2019.00582
- A. A. Farooqi, R. Attar, I. Yaylim, M.Z. Qureshi, M. Todorovska, G.S. Karatoprak, S. Najafi, U.Y. Sabitaliyevich, T.G. Zhenisovna, D.P. de Sousa, X.K. Lin, Piperlongumine as anticancer agent: The story so far about killing many birds with one stone, Cell. Mol. Biol. 2018, 64, 102-107.
- K. Piska, A. Gunia-Krzyzak, P. Koczurkiewicz, K. Wojcik-Pszczola, E. Pekala, Piperlongumine (piplartine) as a lead compound for anticancer agents - Synthesis and properties of analogues: A mini-review, Eur. J. Med. Chem. 2018, 156,
- Y. H. Seo, J.K. Kim, J.G. Jun, Synthesis and biological evaluation of piperlongumine derivatives as potent anti-inflammatory agents, Bioorg. Med. Chem. Lett. 2014, 24, 5727-5730.
- S. Sommerwerk, R. Kluge, D. StrÃ¶hl, L. Heller, A.E. Kramell, S. Ogiolda, P. Liebing, R. Csuk, Synthesis, characterization and cytotoxicity of new piplartine dimers, Tetrahedron 2016, 72, 1447-1454.
- H. Wang, H. Jiang, C. Corbet, S. de Mey,
K. Law, T. Gevaert, O. Feron, M. De Ridder, Piperlongumine increases sensitivity of colorectal cancer cells to radiation: Involvement of ROS production via dual inhibition of glutathione and thioredoxin systems, Cancer Lett. 2019, 450, 42-52.
- Z. S. Deng, C.F. Li, D. Luo, P. Teng, Z.Y. Guo, X. Tu, K. Zou, D.C. Gong, A new cinnamic acid derivative from plant-derived endophytic fungus Pyronema sp., Nat. Prod. Res. 2017, 31, 2413-2419.
- K. Misra, A. Nag, A. Sonawane, N-(2-Bromo-4-fluorophenyl)-3-(3,4-dihydroxyphenyl)- acrylamide (CPAM), a small catecholic amide as an antioxidant, anti-diabetic and antibacterial compound, RSC Adv. 2016, 6, 104632-104641.
- N. Nowacka, R. Nowak, M. Drozd, M. Olech,
R. Los, A. Malm, Antibacterial, Antiradical Potential and Phenolic Compounds of Thirty-One Polish Mushrooms, Plos One 2015, 10, e0140355; doi: 10.1371/journal.pone.0140355.
- E. Sieniawska, R. Sawicki, M. Swatko-Ossor, A. Napiorkowska, A. Przekora, G. Ginalska, E. Augustynowicz-Kopec, The Effect of Combining Natural Terpenes and Antituberculous Agents against Reference and Clinical Mycobacterium tuberculosis Strains, Molecules 2018, 23, E176; doi: 10.3390/molecules23010176.
- G. R. Silveira, K.A. Campelo, G.R.S. Lima, L.P. Carvalho, S.S. Samarao, O. Vieira-da-Motta, L. Mathias, C. R.R. Matos, I.J.C. Vieira, E.J.T. de Melo, E.J. Maria, In Vitro Anti-Toxoplasma gondii and Antimicrobial Activity of Amides Derived from Cinnamic Acid, Molecules 2018, 23, E774; doi: 10.3390/molecules23040774.
- S. T. Xu, D.H. Li, L.L. Pei, H. Yao, C.Q. Wang, H. Cai, H.Q. Yao, X.M. Wu, J.Y. Xu, Design, synthesis and antimycobacterial activity evaluation of natural oridonin derivatives, Bioorg. Med. Chem. Lett. 2014, 24, 2811-2814.
- S. Ghafary, Z. Najafi, M. Mohammadi-Khanaposhtani, H. Nadri, N. Edraki, N. Ayashi, B. Larijani, M. Amini, M. Mahdavi, Novel cinnamic acid-tryptamine hybrids as potent butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study, Arch. Pharm. 2018, 351, e1800115; doi: 10.1002/ardp.201800115.
- J. Gomez, M.J. Simirgiotis, B. Lima, J.D. Paredes, C.M.V. Gabutti, C. Gamarra-Luques, J. Borquez, L. Luna, G.H. Wendel, A.O. Maria, G.E. Feresin, A. Tapia, Antioxidant, Gastroprotective, Cytotoxic Activities and UHPLC PDA-Q Orbitrap Mass Spectrometry Identification of Metabolites in Baccharis grisebachii Decoction, Molecules 2019, 24, E1085; doi: 10.3390/molecules24061085.
- S. L. Guzman-Gutierrez, A. Nieto-Camacho, J.I. Castillo-Arellano, E. Huerta-Salazar, G. Hernandez-Pasteur, M. Silva-Miranda, O. Arguello-Najera, O. Sepulveda-Robles, C.I. Espitia, R. Reyes-Chilpa, Mexican Propolis: A Source of Antioxidants and Anti-Inflammatory Compounds, and Isolation of a Novel Chalcone and epsilon-Caprolactone Derivative, Molecules 2018, 23, E334. doi: 10.3390/molecules23020334.
- J. H. Kim, K.L. Chan, L.W. Cheng, Cinnamic Acid Analogs as Intervention Catysts for Overcoming Antifungal Tolerance, Molecules 2017, 22, E1783; doi:10.3390/molecules22101783.
- A. Peperidou, E. Pontiki, D. Hadjipavlou-Litina, E. Voulgari, K. Avgoustakis, Multifunctional Cinnamic Acid Derivatives, Molecules 2017, 22, E1247; doi: 10.3390/molecules22081247.
- K. Takao, K. Toda, T. Saito, Y. Sugita, Synthesis of Amide and Ester Derivatives of Cinnamic Acid and Its Analogs: Evaluation of Their Free Radical Scavenging and Monoamine Oxidase and Cholinesterase Inhibitory Activities, Chem. Pharm. Bull. 2017, 65, 1020-1027.
- H. Miyachi, Design, synthesis, and structure-activity relationship study of peroxisome proliferator-activated receptor (PPAR)
Î´-selective ligands, Curr. Med. Chem. 2007, 14, 2335-2343.
- L. M. Wang, B. Waltenberger, E.M. Pferschy-Wenzig, M. Blunder, X. Liu, C. Malainer, T. Blazevic, S. Schwaiger, J.M. Rollinger, E.H. Heiss, D. Schuster, B. Kopp, R. Bauer, H. Stuppner, V.M. Dirsch, A.G. Atanasov, Natural product agonists of peroxisome proliferator-activated receptor-gamma (PPAR-gamma): a review, Biochem. Pharmacol. 2014, 92, 73-89.
- J. Wiemann, J. Karasch, A. Loesche, L. Heller, W. Brandt, R. Csuk, Piperlongumine B and analogs are promising and selective inhibitors for acetylcholinesterase, Eur. J. Med. Chem. 2017, 139, 222-231.
- Z. Li, F.C.F. Ip, N.Y. Ip, R. Tong, Highly trans-Selective Arylation of Achmatowicz Rearrangement Products by Reductive
Î³-Deoxygenation and Heck-Matsuda Reaction: Asymmetric Total Synthesis of (-)-Musellarins A-C and Their Analogues, Chem. - Eur. J. 2015, 21, 11152-11157.
- F. H. Clarke, G.B. Silverman, C.M. Watnick, N. Sperber, 3-Azaphenothiazine and dialkylaminoalkyl derivatives, J. Org. Chem. 1961, 26, 1126-1132.
- J. R. Horton, C.B. Woodcock, Q. Chen, X. Liu, X. Zhang, J. Shanks, G. Rai, B.T. Mott, D.J. Jansen, S.C. Kales, M.J. Henderson, M. Cyr,
K. Pohida, X. Hu, P. Shah, X. Xu, A. Jadhav, D.J. Maloney, M.D. Hall, A. Simeonov, H. Fu, P.M. Vertino, X. Cheng, Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5A, J. Med. Chem. 2018, 61, 10588-10601.
- M. R. Stentzel, D.A. Klumpp, Functionalized fluorenes via dicationic electrophiles, Tetrahedron Lett. 2019, 60, 1675-1677.
- W. Tian, J. Li, Z. Su, F. Lan, Z. Li, D. Liang,
C. Wang, D. Li, H. Hou, Novel Anthraquinone Compounds Induce Cancer Cell Death through Paraptosis, ACS Med. Chem. Lett. 2019, 10, 732-736.
- I. A. Moussa, S.D. Banister, C. Beinat,
N. Giboureau, A.J. Reynolds, M. Kassiou, Design, Synthesis, and Structure-Affinity Relationships of Regioisomeric N-Benzyl Alkyl Ether Piperazine Derivatives as sigma-1 Receptor Ligands, J. Med. Chem. 2010, 53, 6228-6239.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeÂ The Effect of Open Access).